2024年
1. Tokunaga Y, Akiyama M, Nakano K, Konaka K, Taguchi A, Maeda T, Sato R, Kanda T, Nakamura Y,Yujiri T, Ohta Y. Diffuse Large B-cell Lymphoma Complicated with Anti-3-hydroxy-3-methylglutaryl-Coenzyme A Reductase Immune-mediated Necrotizing Myopathy: A Case Report.Intern Medin press.
2. Tokunaga Y, Nakamura Y, Ando T, Katsuki K, Sakai K, Fujioka Y, Nono S, Sasaki T, Yamamoto K, Akiyama M, Kawakami F, Kawakami T, Ishida F, Ohta Y,Yujiri T. T-cell large granular lymphocytic leukemia with STAT3 mutation successfully treated with cord blood transplantation.Intern Medin press.
2023年
1. Imai Y, Nagaya S, Araiso Y, Meguro-Horike M, Togashi T, Ohmori K, Makita Y, Sato E, Yujiri T, Nagamori Y, Horike S, Watanabe A, Morishita E. Identification and functional analysis of three novel genetic variants resulting in premature termination codons in three unrelated patients with hereditary antithrombin deficiency.Int J Hematol.117:523-529.2023 .
2. Tanaka N, Kunihiro Y, Kawano R,Yujiri T, Ueda K, Gondo T, Kobayashi T, Matsumoto T. Differential diagnosis of infectious diseases, drug-induced lung injury, and pulmonary infiltration due to underlying malignancy in patients with hematological malignancy using HRCT.Jpn J Rad iol. 41:27-37.2023.
3. 村田 竜也, 小原 健吾, 鹿嶋 聖, 平井 未来, 丸山 恭平, 池田 光泰, 福岡 達仁,湯尻 俊昭 SARS-CoV-2抗原定量検査の活用方法と有用性の検証 医学検査 72: 205–209.2023
2022年
1. Kunihiro Y, Tanaka N, Kawano R,Yujiri T, Ueda K, Gondo T, Kobayashi T, Matsumoto T, Ito K. High-resolution CT
findings of pulmonary infections in patients with hematologic malignancy:
comparison between patients with or without hematopoietic stem cell transplantation.Jpn J Radiol. 40,791–799. 2022.
2. Kajimura Y, Nakamura Y, Hirano T, Tanaka Y, Yamamoto K, Tokunaga Y,
Sasaki T, Oishi K,Yujiri T, Matsunaga K,Tanizawa Y. Significance of alveolar nitric oxide concentration
in the airway of patients with organizing pneumonia after allogeneic hematopoietic
stem cell transplantation. Ann Hematol. 101,1803–1813. 2022.
3. Okamoto Y, Hirano M, Morino K, Kajita MK, Nakaoka S, Tsuda M, Sugimoto KJ, Tamaki S, Hisatake J, Yokoyama H, Igarashi T, Shinagawa A, Sugawara T, Hara S, Fujikawa K, Shimizu S,Yujiri T, Wakita H, Nishiwaki K, Tojo A, Aihara K.Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response.NPJ Syst Biol Appl.8:39. 2022
2021年
1. Kajimura Y, Nakamura Y, Tanaka Y, Tanaka M, Yamamoto K, Matsuguma M,
Tokunaga Y,Yujiri T, Tanizawa Y. Soluble Interleukin-2 Receptor Index Predicts Outcomes After
Cord Blood Transplantation.Transplant Proceedings 53:379-385.2021
2. Tanaka N, Kunihiro Y, Kawano R,Yujiri T, Ueda K, Gondo T, Matsumoto T. Chest complications in immuno-compromisedpatients
without acquired immunodeficiencysyndrome (AIDS): differentiation betweeninfectious
and non-infectious diseases usinghigh-resolution CT findings. Clin Radiol. 76:50-59. 2021.
3. Kunihiro Y, Tanaka N, Kawano R, Matsumoto T, Kobayashi T,Yujiri T, Kubo M, Gondo T, Ito K. Differentiation of pulmonary complications with
extensive ground-glass attenuation on high-resolution CT in immunocompromised
patients. Jpn J Radiol. 39:868-876. 2021.
2020年
1. Nishiwaki K, Sugimoto KJ, Tamaki S, Hisatake J, Yokoyama H, Igarashi
T, Shinagawa A, Sugawara T, Hara S, Fujikawa K, Shimizu S,Yujiri T, Tojo A, Wakita H. Optimal treatment strategy with nilotinib for patients
with newly diagnosed chronic-phase chronic myeloid leukemia based on early
achievement of deep molecular response (MR4.5 ): The phase 2, multicenter
N-Road study. Cancer Med. 9:3742-3751.2020.
２.Imaizumi Y, Iwanaga M, Nosaka K, Ishitsuka K, Ishizawa K, Ito S, Amano
M, Ishida T, Uike N, Utsunomiya A, Ohshima K, Tanaka J, Tokura Y, Tobinai
K, Watanabe T, Uchimaru K, Tsukasaki K; for collaborative Investigators.
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide
hospital-based study. Cancer Sci. 111:4567-4580. 2020
2019年
1. Sunami K, Matsumoto M, Fuchida SI, Omoto E, Takamatsu H, Adachi Y, Choi
I, Fujishima N, Kiguchi T, Miyamoto T, Maeda A, Suzumiya J, Yamamura R,
Nagafuji K, Nakazato T, Kuroda Y,Yujiri T, Takamatsu Y, Harada M, Akashi K. Bortezomib-based strategy with autologous
stem cell transplantation for newly diagnosed multiple myeloma: a phase
II study by the Japan Study Group for Cell Therapy and Transplantation
(JSCT-MM12)Int J Clin Oncol. 24:966-975.2019
2. Takahashi T, Suzuki T, Hiroshige S, Nouno S, Matsumura T, Tominaga T,Yujiri T, Katano H, Sato Y, Hasegawa H. Transient Appearance of Plasmablasts in
the Peripheral Blood of Japanese Patients with Severe Fever with Thrombocytopenia
Syndrome.J Infect Dis.220:23-27.2019
3. Nakamura Y, Tanaka Y, Tanaka M, Yamamoto K, Matsuguma M, KajimuraY,
Tokunaga Y,Yujiri T, Tanizawa Y. Significance of granulocyte colony-stimulating factor-combined
high-dose cytarabine, cyclophosphamide, and total body irradiation in allogeneic
hematopoietic cell transplantation for myeloid malignancies.Transplant Proceedings51:896-900. 2019
4. Akuta K, Kashiwagi H,Yujiri T, Nishiura N, Morikawa Y, Kato H, Honda S, Kanakura Y, Tomiyama Y. A unique
phenotype of acquired Glanzmann thrombasthenia due to non function-blocking
anti-αIIbβ3 autoantibodies.J Thromb Haemost. 1:206-219.2019
5. TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative
neoplasms in Japanese patients.5. Matsuguma M,Yujiri T, Yamamoto K, Kajimura Y, Tokunaga Y, Tanaka M, Tanaka Y, Nakamura Y, Tanizawa
Y. Int J Hematol110:690-698. 2019
6. Kunihiro Y, Hara A, Ikeda E, Nakada N, Murakami T, Hayashi M, Okabe
K,Yujiri T, Kamei H, Tanaka N, Onoda H, Matsumoto T, Ito KA Case of Pulmonary Langerhans
Cell Histiocytosis With Acute Progressive Nodular Lesions Depicted on High-Resolution
Computed Tomography.J Thorac Imaging.34:W144-W146 2019
7. Nawata R, Sugiyama A, Harada K, Shinohara K,Yujiri T. Successful detection of MYD88 L265P mutation in Waldenström's macroglobulinemia
complicated with myelofibrosis using highly sensitive digital PCR.Rinsho Ketsueki.60:903-909. 2019
8. Kunihiro Y, Tanaka N, Kawano R,Yujiri T, Kubo M, Ueda K, Gondo T, Kobayashi T, Matsumoto T. Differential diagnosis
of pulmonary infections in immunocompromised patients using high-resolution
computed tomography.Eur Radiol.29:6089-6099.2019
2018年
1. Hatta Y, Mizuta S, Matsuo K, Ohtake S, Iwanaga M, Sugiura I, Doki N,
Kanamori H, Ueda Y, Yoshida C, Dobashi N, Maeda T,Yujiri T, Monma F, Ito Y, Hayakawa F, Takeuchi J, Kiyoi H, Miyazaki Y, Naoe T.
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined
chemotherapy for Ph+ALL.Ann Hematol.97:1535–1545. 2018
2. Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi
J, Mori T, Hasegawa Y, Kondo T,Yujiri T, Yoshimitsu M, Imada K, Kurahashi S, Kahata K, Ichinohe T, Hirokawa M,
Atsuta Y, Nakaseko C. The Efficacy and Long-Term Outcomes of Autologous
Stem Cell Transplantation in POEMS Syndrome: a Nation-Wide Survey in Japan.Biol Blood Marrow Transplant24:1180-1186. 2018
3. Kawamoto K, Miyoshi H, Suzuki T, Kozai Y, Kato K, Miyahara M,Yujiri T, Oishi N, Choi I, Fujimaki K, Muta T, Kume M, Moriguchi S, Tamura S, Kato
T, Tagawa H, Makiyama J, Kanisawa Y, Sasaki Y, Kurita D, Yamada K, Shimono
J, Sone H, Takizawa J, Seto M, Kimura H, Ohshima K. A distinct subtype
of Epstein Barr virus positive T/NK-cell lymphoproliferative disorder:
Adult patients with chronic active Epstein Barr virus infection-like features.Haematologica103:1018-1028. 2018
4. Sakura T, Hayakawa F, Sugiura I, Murayama T, Imai K, Usui N, Fujisawa
S, Yamauchi T,Yujiri T, Kakihana K, Ito Y, Kanamori H, Ueda Y, Miyata Y, Kurokawa M, Asou N,
Ohnishi K, Ohtake S, Kobayashi Y, Matsuo K, Kiyoi H, Miyazaki Y, Naoe T
for the Japan Adult Leukemia Study Group. High-dose methotrexate therapy
significantly improved survival of adult acute lymphoblastic leukemia:
a phase III study by JALSG.Leukemia32:626-632. 2018
2017年
1. Nakamura Y, Matsuguma M, Tokunaga Y, Yamamoto K, Tanaka M, Tanaka Y,
Yujiri T, Tanizawa Y. Successful treatment of Behçet’s disease associated with
acute myeloid leukemia with myelodysplasia-related changes using azacitidine
and tacrolimus before allogeneic hematopoietic stem cell transplantation.
Intern Med 56:1199-1202. 2017
2. Ichimura T, Yoshida K, Okuno Y, Yujiri T, Nagai K, Nishi M, Shiraishi Y, Ueno H, Toki T, Chiba K, Tanaka H, Muramatsu
H, Hara T, Kanno H, Kojima S, Miyano S, Ito E, Ogawa S, Ohga S. Diagnostic
challenge of Diamond–Blackfan anemia in mothers and children by whole-exome
sequencing. Int J Hematol 105:515-520. 2017
3. Nawata T, Kubo M, Okuda S, Omoto M, Yujiri T, Kanda T, Yano M. Successful treatment with intravenous cyclophosphamide
for anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis
associated with myelodysplastic syndrome. Scand J Rheumatol 46:496-498. 2017
2016年
1. Sugiyama A, Yujiri T, Tanaka M, Tanaka Y, Nakamura Y, Tanizawa Y. SIRT1 is downregulated during
peripheral blood stem cell mobilization in healthy donors by granulocyte-colony
stimulating factor. Ann Hematol. 95:1381–1382. 2016
2. Tanaka N, Kunihiro Y, Kobayashi T, Yujiri T, Kido S, Ueda K, Matsunaga N. High-resolution CT findings of idiopathic
pneumonia syndrome after haematopoietic stem cell transplantation: based
on the updated concept of idiopathic pneumonia syndrome by the American
Thoracic Society in 2011. Clin Radiol. 71:953-9. 2016
3. Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, Imoto N,
Kohsaka S, Kunita A, Doi K, Sakura T, Yujiri T, Kondo E, Fujimaki K, Ueda Y, Aoyama Y, Ohtake S, Takita J, Sai E, Taniwaki
M, Kurokawa M, Morishita S, Fukayama M, Kiyoi H, Miyazaki Y, Naoe T, Mano
H. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents
and young adults. Nat Genet 48:569-74. 2016
4. Itonaga H, Iwanaga M, Aoki K, Aoki J, Ishiyama K, Ishikawa T, Sakura
T, Fukuda T, Najima Y, Yujiri T, Mori T, Kurokawa M, Nawa Y, Uchida N, Morishita Y, Hashimoto H, Eto T,
Hirokawa M, Morishima Y, Nagamura-Inoue T, Atsuta Y, Miyazaki Y. Impacts
of graft-versus-host disease on outcomes after allogeneic hematopoietic
stem cell transplantation for chronic myelomonocytic leukemia: A nationwide
retrospective study.Leukemia Res 41:48-55. 2016
5. Nakamura Y, Tanaka Y, Tanaka M, Sugiyama A, Yamamoto K, Tokunaga Y,
Yujiri T, Tanizawa Y. Soluble interleukin-2 receptor index predicts the development
of acute graft-versus-host disease after allogeneic hematopoietic stem
cell transplantation from unrelated donors. Int J Hematol 103:436-43. 2016
6. Nishiwaki S, Imai K, Mizuta S, Kanamori H, Ohashi K, Fukuda T, Onishi
Y, Takahashi S, Uchida N, Eto T, Nakamae H, Yujiri T, Mori S, Nagamura-Inoue T, Suzuki R, Atsuta Y, Tanaka J. Impact of MRD
and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a
study from the Adult ALL WG of the JSHCT. Bone Marrow Transplant 51:43-50. 2016
2015年
1. Sugiyama A, Yujiri T, Tanaka M, Tanaka Y, Nakamura Y, Tanizawa Y. Altered expression of circadian
clock genes during peripheral blood stem cell mobilization induced by granulocyte
colony-stimulating factor. Chronobiol Int 32: 934-41, 2015
2. Nakamura Y, Tanaka Y, Tanaka M, Sugiyama A, Tokunaga Y, Suehiro Y, Takeda
K, Yujiri T, Tanizawa Y. Effect of early posttransplantation tacrolimus concentration
on the development of acute graft-versus-host disease after cord blood
transplantation. Journal of Hematopoietic Cell Transplantation 4: 74-81, 2015
2014年
1. Hayakawa F, Sakura T, Yujiri T, Kondo E, Fujimaki K, Sasaki O, Miyatake J, Handa H, Ueda Y, Aoyama Y,
Takada S, Tanaka Y, Usui N, Miyawaki S, Suenobu S, Horibe K, Kiyoi H, Ohnishi
K, Miyazaki Y, Ohtake S, Kobayashi Y, Matsuo K, Naoe T. Markedly improved
outcomes and acceptable toxicity in adolescents and young adults with acute
lymphoblastic leukemia following treatment with a pediatric protocol: a
phase II study by the Japan Adult Leukemia Study Group. Blood Cancer Journal 4: e252, 2014
2. Yujiri T, Nakamura Y, Oota I, Nakano K, Tanizawa Y. Acquired von Willebrand syndrome
associated with monoclonal gammopathy of undetermined significance. Ann Hematol. 93:1427-1428, 2014
3. Yujiri T, Tanaka M, Taguchi A, Tanaka Y, Nakamura Y, Tanizawa Y. Reactivation of
hepatitis B virus in a hepatitis B surface antigen-negative patient with
acute promyelocytic leukemia treated with arsenic trioxide. Ann Hematol. 93:351-352, 2014
2013年
1. Kanamori H, Mizuta S, Kako S, Kato H, Nishiwaki S, Imai K, Shigematsu
A, Nakamae H, Tanaka M, Ikegame K, Yujiri T, Fukuda T, Minagawa K, Eto T, Nagamura-Inoue T, Morishima Y, Suzuki R,
Sakamaki H, Tanaka J Reduced-intensity allogeneic stem cell transplantation
for patients aged 50 years or older with B-cell ALL in remission: a retrospective
study by the Adult ALL Working Group of the Japan Society for Hematopoietic
Cell Transplantation. Bone Marrow Transplant. 48:1513-1518, 2013
2. Nakamura Y, Mitani N, Ishii A, Hayashi S, Yujiri T, Ikeda E, Tanizawa Y. Idiopathic pneumonia syndrome with thrombotic microangiopathy-related
changes after allogeneic hematopoietic stem cell transplantation. Int J Hematol 98:496-498, 2013
3. Nakasone H, Kanda J, Yano S, Atsuta Y, Ago H, Fukuda T, Kakihana K,
Adachi T, Yujiri T, Taniguchi S, Taguchi J, Morishima Y, Nagamura T, Sakamaki H, Mori T,
Murata M; GVHD Working Group of the Japan Society for Hematopoietic Cell
Transplantation. A case-control study of bronchiolitis obliterans syndrome
following allogeneic hematopoietic stem cell transplantation. Transpl Int. 26:631-639, 2013
4. Tanaka M, Yujiri T, Ito S, Okayama N, Takahashi T, Shinohara K, Azuno Y, Nawata R, Hinoda
Y, Tanizawa Y. JAK2 46/1 haplotype is associated with JAK2 V617F-positive
myeloproliferative neoplasms in Japanese patients. Int J Hematol 97:409–413, 2013
2012年
1. Mizuta S, Matsuo K, Maeda T, Yujiri T, Hatta Y, Kimura Y, Ueda Y, Kanamori H, Usui N, Akiyama H, Takada S, Yokota
A, Takatsuka Y, Tamaki S, Imai K, Moriuchi Y, Miyazaki Y, Ohtake S, Ohnishi
K, Naoe T. Prognostic factors influencing clinical outcome of allogeneic
hematopoietic stem cell transplantation following imatinib-based therapy
in BCR–ABL-positive ALL. Blood Cancer Journal 2, e72, 2012.
2. Tanaka M, Yujiri T, Tanaka Y, Mitani N, Tanimura A, Tanizawa Y. Alteration of Dickkopf-1
and receptor activator of nuclear factor-kB ligand during peripheral blood
stem cell mobilization in healthy donors by granulocyte colony stimulating
factor. Bone Marrow Transplant 47, 1143-1144, 2012.
2011年
1. Tanimura A, Yujiri T, Tanaka Y, Tanaka M, Mitani N, Nakamura Y, Ariyoshi K, Tanizawa Y. Activation
of the unfolded protein response in primary acute myeloid leukemia cells.
Int J Hematol 94, 300-302, 2011
2. Tanaka N, Kunihiro Y, Yujiri T, Ando T, Gondo T, Kido S, Matsunaga N. High-resolution computed tomography
of chest complications in patients treated with hematopoietic stem cell
transplantation. Jpn J Radiol. 29:229-235. 2011
3. Iida M, Fukuda T, Ikegame K, Yoshihara S, Ogawa H, Taniguchi S, Takami
A, Abe Y, Hino M, Etou T, Ueda Y, Yujiri T, Matsui T, Okamura A, Tanaka J, Atsuta Y, Kodera Y, Suzuki R. Use of mycophenolate
mofetil for patients received allogeneic hematopoietic stem cell transplantation
in Japan. Int J Hematol 93,523-531,2011
4. Suga K, Kawakami Y, Matsunaga N, Yujiri T, Nakazora T, Ariyoshi K. F-18 FDG PET/CT findings of a case of sacral
nerve root neurolymphomatosis that occurred during chemotherapy. Clin Nucl Med. 36:73-76, 2011
5. Kunihiro Y, Tanaka N, Ando T, Yujiri T, Matsunaga N. Engraftment Syndrome After Hematopoietic Stem Cell Transplantation:
High-resolution Computed Tomography Findings in 2 Patients. J Thorac Imaging 26:W23-25,2011
6. Mitani N, Yujiri T, Tanaka Y, Tanaka M, Fujii Y, Hinoda Y, Tanizawa Y. Hematopoietic progenitor
cell count, but not immature platelet fraction value, predicts successful
harvest of autologous peripheral blood stem cells. J Clin Apheresis 26:105-110,2011
7. Miyazaki K, Yamaguchi M, Suzuki R, Kobayashi Y, Maeshima AM, Niitsu
N, Ennishi D, Tamaru J-i, Ishizawa K, Kashimura M, Kagami Y, Sunami K,
Yamane H, Nishikori M, Kosugi H, Yujiri T, Hyo R, Katayama N, Kinoshita T, Nakamura S. CD5-positive diffuse large
B-cell lymphoma: A retrospective study in 337 patients treated by chemotherapy
with or without rituximab. Ann Oncol 22:1601-1607,2011
8. Mizuta S, Matsuo K, Yagasaki F, Yujiri T, Hatta Y, Kimura Y, Ueda Y, Kanamori H, Usui N, Akiyama H, Miyazaki Y,
Ohtake S, Atsuta Y, Sakamaki H, Kawa K, Morishima Y, Ohnishi K, Naoe T,Ohno
R. Pre-transplant imatinib-based therapy improves the outcome of allogeneic
hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic
leukemia. Leukemia 25, 41-47, 2011
9. Yujiri T, Tanaka Y, Tanaka M, Takahashi T, Tanizawa Y. Alteration in serum B cell-activating
factor levels in patients with idiopathic thrombocytopenic purpura after
Helicobacter pylori eradication therapy. Brit J Haematol. 152, 496-498, 2011
2010年
1. Asakura M, Ikegame K, Yoshihara S, Taniguchi S, Mori T, Etoh T, Takami
A, Yoshida T, Fukuda T, Hatanaka K, Kanamori H,Yujiri T, Atsuta Y, Sakamaki H, Suzuki R, Ogawa H. Use of foscarnet for cytomegalovirus
infection after allogeneic hematopoietic stem cell transplantation from
a related donor. Int J Hematol 92, 351-359, 2010
2. Yujiri T, Tagami K, Tanaka Y, Mitani N, Nakamura Y, Ariyoshi K, Ando T, Tanizawa
Y. Increased serum levels of high-mobility group box 1 protein in patients
who developed acute graft-versus-host disease after allogeneic haematopoietic
stem cell transplantation. Eur J Haematol. 85, 366-367, 2010
3. Ando T, Mitani N, Yamashita K, Takahashi T, Ohama E, Miyata H,Yujiri T, Tanizawa Y. Cytomegalovirus ventriculoencephalitis in a reduced-intensity
conditioning cord blood transplant recipient. Transpl Infect Dis 12,441-445, 2010
4. Ando T, Mitani N, Matsunaga K, Nakazora T, Gondo T, Yujiri T, Tanizawa Y. Gemtuzumab ozogamicin therapy for isolated extramedullary
AML relapse after allogeneic hematopoietic stem-cell transplantation. Tohoku J Exp Med 220,121-126, 2010
2009年以前
Tanaka Y, Yujiri T, Tanaka M, Mitani N, Tanimura A, Tanizawa Y. Alteration of adipokines
during peripheral blood stem cell mobilization induced by granulocyte colony-stimulating
factor. J Clin Apheresis 24, 205-208, 2009
Yujiri T, Tanaka Y, Tanaka M, Tanizawa Y. Fluctuations in thrombopoietin, immature
platelet fraction, and glycocalicin levels in a patient with cyclic thrombocytopenia.
Int J Hematol 90, 429-430, 2009
Ando T, Mitani N, Matsui K, Yamashita K, Nomiyama J, Tsuru M, Yujiri T, Tanizawa Y. Recurrent extramedullary relapse of acute myelogenous leukemia
after allogeneic hematopoietic stem cell transplantation in a patient with
chromosomal abnormality t(8;21) and CD56 positivity. Int J Hematol 90, 374-377, 2009
Tagami K, Yujiri T, Takahashi T, Kizuki N, Tanaka Y , Mitani N, Nakamura Y, Ariyoshi K, Ando
T, Gondo T, Tanizawa Y. Increased serum levels of matrix metalloproteinase-9
in acute graft-versus-host disease after allogeneic haematopoietic stem
cell transplantation. Int J Hematol 90, 248-252, 2009
Konno H, Yamamoto T, Yamazaki K, Gohda J, Akiyama T, Semba K, Goto H, Kato
A, Yujiri T, Imai T, Kawaguchi Y, Su B, Takeuchi O, Akira S, Tsunetsugu-Yokota Y,
Inoue J. TRAF6 Establishes Innate Immune Responses by Activating NF-κB
and IRF7 upon Sensing Cytosolic Viral RNA and DNA. PLoS ONE 4, e5674, 2009
Tanimura A, Yujiri T, Tanaka Y, Hatanaka M, Mitani N, Nakamura Y, Mori K, Tanizawa Y. The Anti-apoptotic
Role of the Unfolded Protein Response in Bcr-Abl-positive Leukemia Cells.
Leukemia Res. 33, 924-928, 2009
Yujiri T, Miyazaki M, Imoto S. A novel t(11;14)(q23;q32) in a patient with myelodysplastic
syndrome. Cancer Genet Cytogenet, 188, 124-125, 2009
Yanada M, Sugiura I, Takeuchi J, Akiyama H, Maruta A, Ueda Y, Usui N, Yagasaki
F, Yujiri T, Takeuchi M, Nishii K, Kimura Y, Miyawaki S, Narimatsu H, Miyazaki Y,
Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R. Prospective monitoring of
BCR-ABL transcript levels in patients with Philadelphia chromosome-positive
acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy.Brit J Haematol. 143, 503-510, 2008
Ando T, Yujiri T, Nomiyama J, Mitani N, Seguchi M, Matsubara A, Tanizawa Y. Allogeneic
peripheral blood stem cell transplantation from related donors mismatched
at 2 HLA loci in the host-versus-graft direction. Tohoku J Exp Med 214, 159-163, 2008
Yujiri T, Tagami T, Tanimura A, Tanizawa Y. Alteration of adrenergic signals during
peripheral blood stem cell mobilization induced by granulocyte colony-stimulating
factor. Leukemia Res 32, 195-197, 2008
Nakamura Y, Tanaka Y, Ando T, Sato Y, Yujiri T, Tanizawa Y. Successful engraftment of the second reduced-intensity conditioning
cord blood transplantation (CBT) for a patient who developed graft rejection
and infectious complications after the first CBT for AML. Bone Marrow Transplant 40, 395-396, 2007
Nakamura Y, Yujiri T, Ando T, Hisano S, Tanizawa Y. Nephrotic syndrome associated with thrombotic
microangiopathy following allogeneic stem cell transplantation for myelodysplastic
syndrome. Brit J Haematol 136, 857-858, 2007
Tagami K*, Yujiri T*, Tanimura A, Mitani N, Nakamura Y, Ariyoshi K, Ando T, Fujii Y, Tanizawa
Y. Elevation of serum high-mobility group box 1 protein during granulocyte
colony stimulating factor-induced peripheral blood stem cell mobilization.
Brit J Haematol 135,567-569, 2006 (*These authors contributed equally to this work)
Nakamura Y, Yujiri T, Tanizawa Y. Role of MEK kinase 1 in Bcr-Abl-Induced Self-Renewal Activity
of Embryonic Stem Cells. Bull Yamaguchi Med Sch53,1-4, 2006
Yujiri T, Katsuki K, Miyazaki M, Ando T, Tsuru M, Nomiyama J, Tanizawa Y. A Case
of Hand-Mirror Cell Variant of Multiple Myeloma. Int J Hematol 83, 373-374, 2006
Ando T, Yujiri T, Mitani N, Takeuchi H, Nomiyama J, Suguchi M, Matsubara A, Tanizawa Y.
Donor cell-derived acute myeloid leukemia after unrelated umbilical cord
blood transplantation. Leukemia 20, 744-745,2006
Nakamura Y, Yujiri T, Nawata R, Tagami K, Tanizawa Y. MEK kinase 1 is Essential for Bcr-Abl
Induced STAT3 and Self-Renewal Activity in Embryonic Stem Cells. Oncogene 24, 7592-7598, 2005
Ueda K, Kawano J, Takeda K, Yujiri T, Tanabe K, Anno T, Akiyama M, Nozaki J, Yoshinaga T, Koizumi A, Shinoda
K, Oka Y, Tanizawa Y. Endoplasmic Reticulum Stress Induces Wfs1 Gene Expression
in Pancreatic-cells via Transcriptional Activation. Eur J Endocrinol 153, 167-176, 2005
Li Y, Minamino T, Tsukamoto O, Yujiri T, Shintani Y, Okada K, Nagamachi Y, Fujita M, Hirata A, Sanada S, Asanuma
H, Takashima S, Hori M, Johnson GL, Kitakaze M. Ablation of MEKK1 Suppresses
Intimal Hyperplasia by Impairing Smooth Muscle Cell Migration and uPA Expression
in a Mouse Blood Flow Cessation Model. Circulation 111, 1672-1678, 2005
Ando T, Yujiri T, Tominaga T, Shinya S, Takahashi T, Nomiyama J, Seguchi M, Matsubara A,
Fujii Y, Tanizawa Y. Autografting followed by a reduced-intensity conditioning
unrelated donor cord blood transplantation for a patient with refractory
multiple myeloma: successful engraftment with minimal toxicity. Eur J Haematol 74, 175-179, 2005
Yujiri T, Sato Y, Tanizawa Y. Sustained cytogenetic remission induced by imatinib
mesylate in a chronic myeloid leukemia patient who had relapsed into lymphoid
crisis after allogeneic hematopoietic stem cell transplantation. Int J Hematol 80, 67-69, 2004
Takahashi T, Yujiri T, Tanizawa Y. Helicobacter pylori and chronic ITP: the discrepancy in the
clinical responses to eradication therapy might be due to differences in
the bacterial strains. Blood 104, 594, 2004
Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, Okubo M, Zaitsu Y, Ariyoshi K,
Nakamura Y, Nawata R, Oka Y, Shirai M, Tanizawa Y. Molecular mimicry by
Helicobacter pylori CagA protein may be involved in the pathogenesis of
H. pylori-associated chronic idiopathic thrombocytopenic purpura. Brit J Haematol 124, 91-96, 2004
Nawata R., Yujiri T., Nakamura Y., Ariyoshi K., Takahashi T., Sato Y., Oka Y., Tanizawa Y.
MEK Kinase 1 mediates the anti-apoptotic effect of the Bcr-Abl oncogene
through NF-kB activation. Oncogene 22,7774-7780, 2003
Cuevas BD, Abell AN, Witowsky JA, Yujiri T, Johnson NL, Kesavan K, Ware M, Jones PL, Weed SA, DeBiasi RL, Oka Y,
Tyler, Johnson GL. MEKK1 regulates calpain-dependent proteolysis of focal
adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO J. 22, 3346-3355, 2003
Yujiri, T., Nawata, R., Takahashi, T., Sato, Y., Tanizawa, Y., Kitamura, T., Oka,
Y. MEK kinase 1 interacts with focal adhesion kinase and regulates insulin
receptor substrate-1 expression. J. Biol. Chem. 278, 3846-3851, 2003
Minamino T, Yujiri T, Terada N, Taffet GE, Michael LH, Johnson GL, Schneider MD. MEKK1 is essential
for cardiac hypertrophy and dysfunction induced by Gq. Proc Natl Acad Sci U S A. 99, 3866–3871,2002
Yujiri,T., Ware M., Oyer R., Russell D., Zaitsu Y., Clarke P., Tyler K., Oka Y.,
Henson P., Johnson GL. Cell migration and c-Jun NH2-terminal kinase but
not NFkB are regulated by MEK Kinase 1. Proc Natl Acad Sci U S A. 97, 7272-7277, 2000
Garrington T., Ishizuka T., Papst P.J., Chayama K., Webb S., Yujiri T., Sun W., Sather S., Russell D.M., Gibson S.B., Keller G., Gelfand E.W.,
Johnson G.L. MEKK2 gene disruption causes loss of cytokine production in
response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells.
EMBO J. 19, 5387-5395, 2000
Minamino T, Yujiri T, Papst PJ, Chan ED, Johnson GL, Terada N. MEKK1 suppresses oxidative stress-induced
apoptosis of embryonic stem cell-derived cardiac myocyte. Proc Natl Acad Sci U S A. 96, 15127-32, 1999
Yujiri, T., Fanger, G.R., Garrington, T.P., Schlesinger, T. K., Gibson, S., Johnson,
G.L. MEK kinase 1 transduces JNK activation in response to changes in microtubule
cytoskeleton. J. Biol. Chem. 274,12605-10. 1999
Yujiri, T., Sather, S., Fanger, G. R., and Johnson, G. L. Role of MEKK1 in cell
survival and activation of JNK and ERK pathways defined by targeted gene
disruption. Science 282, 1911-4. 1998
Schlesinger, T. K., Fanger, G. R.,Yujiri, T., Johnson, G. L. The TAO of MEKK. Front Biosci Nov 15;3:D1181-6. 1998
Jarpe, M. B., Widmann, C., Knall, C., Schlesinger, T. K., Gibson, S., Yujiri, T., Fanger, G. R., Gelfand, E. W., and Johnson, G. L. Anti-apoptotic versus
pro-apoptotic signal transduction: checkpoints and stop signs along the
road to death. Oncogene 17, 1475-82. 1998
Kamei S, Shinohara K, Yujiri T, Shigemoto K, Oeda E, Yohena H.Automatic isolation of bone marrow mononuclear
cells using Fenwal CS-3000 Plus blood cell separator. Bull Yamaguchi Med Sch 39: 31-35. 1992
Shinohara K, Yujiri T, Kamei S, Ayame H, Tanaka M, Ando S, Tajiri M,and Kurimoto F. Increased
production of GM-CSF, IL-3, IL-6 by the stimulated peripheral blood mononuclear
cells in patients with aplastic anemia. Jpn Arch Int Med 39: 183-189. 1992
Shinohara K, Yujiri T, Kamei S, Ayame H, Tanaka M, Ando S, and Tajiri M.Absence of point mutation
of N-ras oncogene in bone marrow cells with aplastic anemia. Int J Cell Cloning 10: 94-98. 1992
Yujiri T, Shinohara K, and Kurimoto K. Fluctuations in serum cytokine levels in
the patient with cyclic neutropenia. Am J Hematol. 39:144-145.1992
特 許
特開2016-077221 :BCR−ABL阻害剤耐性関連変異の検出方法及びこれを用いたBCR−ABL阻害剤耐性を予測するためのデータ取得方法
大場 光芳, 阿部 健一, 山野 博文, 湯尻 俊昭
WO2019-004334：骨髄増殖性腫瘍に関連する遺伝子変異評価用キット
高光 恵美、大場 光芳、森弘 惇一、山野 博文, 松隈 雅史、湯尻 俊昭
WO2019-004335:遺伝子変異評価方法、遺伝子変異評価用キット
高光 恵美, 大場 光芳, 森弘 惇一, 山野 博文, 松隈 雅史, 湯尻 俊昭